This activity is designed for clinical specialists with a fundamental clinical understanding of assessment, diagnosis, treatment, and ongoing management of patients with hepatitis C.

After participating in this activity, the physician should be able to:

• Describe the current standard of care for treatment of hepatitis C virus (HCV) infection using combination therapy
  
  
• Discuss emerging improvements in treatment for HCV and HCV/HIV coinfection based on study results and their implications from clinical trials using pegylated interferon/ribavirin combination therapy and pegylated interferon monotherapy
  
  
• Describe potential approaches to treatment, including dosing strategies and duration of treatment, that incorporate pegylated interferon into established standards of care

World Wide Web pages are copyrighted and may not be reproduced in any form
without the express written consent of Projects In Knowledge, Inc.
Copyright © 2004, Projects In Knowledge, Inc. All rights reserved.

For questions or comments regarding this web site please contact: Webmaster